Ruirong Ye
8PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 27, 2026
Synthesis and antitumor mechanism investigation of iridium(III)/rhenium(I) complexes with 4-phenylimidazole ligands.Lin-Yuan Zhu, Chun-Rong Jiang, Hou Zhu
|Sep 22, 2025
Iridium(III)/rhenium(I) complexes bearing NLG919 as the ligand for enhanced triple-negative breast cancer therapy.Hou Zhu, Yong-Sheng Yang, Lin-Yuan Zhu
|May 07, 2024
Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity.Kai Xie, Xing-Yun Lu, Hou Zhu
|Sep 08, 2022
Lysosome-targeted cyclometalated iridium(III) complexes: JMJD inhibition, dual induction of apoptosis, and autophagy.Jun-Jian Lu, Xiu-Rong Ma, Kai Xie
|Aug 30, 2022
8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy.Xiurong Ma, Junjian Lu, Peixin Yang
|May 10, 2022
Novel heterobimetallic Ir(III)-Re(I) complexes: design, synthesis and antitumor mechanism investigation.Jun-Jian Lu, Xiu-Rong Ma, Kai Xie
Pageof 2
